KEYNOTE-355 Archives - Medical Conferences

Olaparib maintenance has favourable safety profile in TNBC

Presented By

Prof. Hope Rugo, UCSF Helen Diller Family Comprehensive Cancer Center, CA, USA

Trial

Phase 2, KEYLYNK-009

Conference

SABCS 2023

Type

News article

11 January 2024 14:57

Presented By

Dr Javier Cortés, Vall d'Hebron Institute of Oncology, Spain

Trial

Phase 3, KEYNOTE-355

Conference

SABCS 2021

Type

Peer-reviewed article

31 January 2022 17:40

Presented By

Prof. Hope Rugo, University of California, San Francisco, USA

Trial

Phase 3, KEYNOTE-355

Conference

ESMO 2021

Type

Peer-reviewed article

19 November 2021 09:48

Presented By

Dr Javier Cortés & Catherine M. Kelly

Trial

KEYNOTE-355

Conference

ASCO 2020

Type

Peer-reviewed article

8 September 2020 09:32